Profylactic Treatment for Patients in Risk Osteoporosis (PF-Jarlsberg)
Osteopenia or Osteoporosis
About this trial
This is an interventional prevention trial for Osteopenia or Osteoporosis
Eligibility Criteria
Inclusion Criteria: Osteopeni patients (OP) of both genders above 55 years of age. OPs are defined as patients with T-score below 0.0 but larger than -2.5. Exclusion Criteria: • Eating disorder Known gastrointestinal disorder. Abnormal liver or kidney function. Diabetes mellitus type I. Diabetes type II without sufficient control. Suffering from verified cancer. Under systemic treatment with corticosteroids or other immunosuppressive drugs the last 3 weeks before start of the trial treatment. Under active antiresorptive treatment or anabolic treatment. Participating in another clinical trial with pharmaceuticals the last six weeks before start of this trial treatment. Known milk product allergy. Not able to understand information. Do not want or not able to give written consent to participate in the study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Treatment 1
Treatment 2
1000 mg Calcium tablets + 20µg vitamin D and optimal efficacy dose of Jarlsberg cheese
1000 mg Calcium tablets + 20µg vitamin D